GABAB receptors are a subclass of receptors for y-amino-n-butyric acid (GABA) that are also activated by the antispastic drug fi-p-chlorophenyl-GABA (baclofen). One effect of baclofen is to inhibit excitatory transmission from CA3 to CA, hippocampal pyramidal cells. To identify the ionic mechanism of GABAB-receptor-mediated depression, we have studied the effect of baclofen and GABA on ionic currents in voltage-clamped CA3 pyramidal cell somata in rat hippocampal slice cultures. Baclofen (10 pM) induced an inwardly rectifying outward current that reversed at -74 ± 4.3 mV (mean * SD). This appeared to be a K+ current since (') its reversal potential showeo the expected shift when extracellular K+ concentration was changed and (ii) it was blocked by external Ba2' or internal Cs'. The action of baclofen was closely imitated by GABA after the GABAA-mediated Cl-current had been abolished with pitrazepin (10 #M); under these conditions, GABA (100 pM) also produced an inwardly rectifying, Ba2+-sensitive current with a reversal potential identical to that of the badofen-induced current. When outward currents were blocked with internal Cs', the residual inward voltagedependent Ca21 current was not changed by baclofen. It is concluded that the primary effect of GABAB-receptor activation in these neurones is to increase K+ permeability rather than to reduce Ca21 permeability.
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Two subclasses of receptors for the central inhibitory neurotransmitter 4-amino-n-butyric acid (y-aminobutyric acid, GABA) have been defined and designated GABAA and GA-BAB receptors (1, 2) . GABAA receptors are selectively activated by the GABA analogue muscimol and mediate an increased Cl-conductance (3, 4) . Effects of GABAA activation are blocked by convulsants such as bicuculline and picrotoxin. A selective agonist for the bicuculline-insensitive GABAB receptor is the antispastic agent 8-p-chlorophenyl-GABA (baclofen) (1) . The principal effect of baclofen is to depress transmitter release from certain excitatory pathways, including intraspinal primary afferents (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) and Schaffer commissural fibers in the hippocampus (15-18).
The ionic mechanism responsible for this effect of baclofen action is not clear. In cell bodies of primary afferent fibers baclofen shortens the action potential (19, 20) , from which it has been suggested that it reduces voltage-dependent Ca2+ conductance (19) . In hippocampal cell somata, on the other hand, baclofen induces a membrane hyperpolarization and an increased input conductance, suggesting an increased K+ permeability (21) (22) (23) ; if such an effect occurred at nerve terminals it could also affect action potential duration and reduce Ca2' influx in the absence of a direct effect on Ca2+ currents.
To obtain better resolution of the ionic permeability changes induced by baclofen, we have studied its effect on voltage-clamped hippocampal neurones under conditions in which actions on K+ and Ca2+ conductance can be discriminated. We find that baclofen induces a K+ current without inhibiting directly the slow inward Ca2+ current. We also show that the effect of baclofen can be replicated by GABA when GABAA receptors are blocked, so supporting the view (2) that GABA may be the endogenous ligand for baclofen receptors.
MATERIALS AND METHODS
Experiments were performed on hippocampal slices prepared from 7-day-old Wistar rats and cultured organotypically for 3-5 weeks in vitro as described previously (24, 25 washing out the baclofen and could be induced several times on the same cell at intervals of 10 min or so without loss of sensitivity. The action of (±)-baclofen was imitated by 10 ,uM (-)-baclofen but not by 10 Baclofen Does Not Inhibit Ca2+ Current. In Fig. 1 an inward current deflection may be noted after the initial transient outward current during the depolarizing command. This is generated by the slow inward Ca2+ current Ice previously described in hippocampal neurones (27, 36) . ICa itself is largely masked by subsequent outward K+ currents during the depolarizing step, but its continued presence throughout the command is suggested by the inward tail current when the holding potential is restored. This inward tail may reflect both persistence ofICa (27) and a residual Ca2+-activated Clcurrent (43) . In baclofen solution, ICa is less apparent during the depolarizing command, but the repolarizing tail current is still present; this suggests that the reduction in ICa may be secondary to the increased outward current. To test the effect of baclofen on ICa itself, outward currents were inhibited by injecting Cs+ into the neurone by using a CsCl-filled microelectrode (36) . This also inhibited the outward current generated by baclofen. Under these conditions depolarizing Fig. 1) . Outward current upwards. Note that pitrazepin reversed the GABAinduced current from inward to outward but did not affect the baclofen-induced current. The graphs in B show the voltage dependence of GABA-and baclofen-induced currents recorded in the absence (o, o) and presence (v, *) of pitrazepin. Graphs were obtained from subtracted I/V curves as described for Fig. 2 . commands generated a net inward Ca2+ current as shown in Fig. 5 . Two components of this current can be discerned, a rapid transient current and a more sustained component, as previously reported in adult rat hippocampal cells (27, 37) . These currents were inhibited in Ca2 -free solution or by addition of 10-100 uM Cd2 . In contrast, baclofen did not inhibit either component.
DISCUSSION
The principal effect of baclofen on hippocampal neurones detected in these experiments is the generation of an outward membrane current Ibac. This we attribute to an increased K+ conductance for three reasons. (i) The reversal potential for Ibac shows the expected dependence on external K+ concentration; (it) Ibac is inhibited by external Ba2+; and (iii) it is also inhibited by internal Cs+. This current is presumably responsible for the hyperpolarization of hippocampal cells previously reported (21) (22) (23) . The inward rectification would explain why this hyperpolarization appeared to diminish when the cells were depolarized (22) . A comparable current probably underlies the hyperpolarizing effect of baclofen on Onchidium neurones (38) .
This effect of baclofen probably results from an action on GABAB receptors since it could be replicated by GABA when the GABAA-mediated increase in Cl-conductance was blocked with pitrazepin. Newberry and Nicoll (39) have also detected a shift in the reversal potential for the effect of GABA on hippocampal CA1 neurones to more hyperpolar ized levels in the presence of the GABAA antagonist bicuculline. In the absence of a selective GABAB antagonist we cannot be certain that this reflects an effect of GABA and baclofen on the same receptor, as distinct from independent activation of the same conductance mechanism via different receptors, although ligand-binding studies (2) support a common receptor interaction.
At rest potentials between -50 and -70 mV the increased K+ conductance produced by GABA via GABAB receptors was much less than the increased Cl-conductance associated with GABAA-receptor activation, so that in the absence of GABAA antagonists the latter dominates the overall response to exogenous GABA. Thus, inhibition of the K+ component with Ba2' did not noticeably change the reversal potential for GABA in the absence of pitrazepin. The increased K+ conductance becomes greater at membrane potentials beyond -80 mV, but it is difficult to imagine its significance during simultaneous activation of GABAA receptors. Activation of this K+ current might be of more importance to the effects of synaptically released GABA if, as suggested by Newberry and Nicoll (39) , there is a temporal dissociation between the activation of GABAA and GABAB receptors.
We could detect no effect of baclofen on ICa in hippocampal neurones under conditions in which the K+ conductance was blocked. We therefore suggest that the inhibition of transmitter release by baclofen postulated to occur in the terminals of CA3 cell axons (13-15) is more likely to result from the indirect effects of the increased K+ conductance on Ca2+ influx than from a direct effect on Ca2+ conductance per se. This may also be true for the effect of baclofen on mammalian primary afferent fibers, since baclofen failed to reduce the "Ca2+ component" of the action potential in sensory spinal ganglion cells impaled with Cs'-filled microelectrodes (20) in which lbac would be suppressed.
In subsequent experiments we have observed that the inward currents produced by baclofen and GABA (in the presence of pitrazepin) at membrane potentials negative to their reversal potential were also blocked in a voltage-dependent manner by 1 mM external Cs' (unpublished observations).
Since other inwardly rectifying K+ currents show voltagedependent block by Cs' (40) (41) (42) this supports our view that both compounds activate the same species of inward-rectifying K+ conductance.
